COL1 c -前肽裂解位点突变导致高骨量成骨不全。
文章的细节
-
引用
-
Lindahl K, Barnes AM, Fratzl-Zelman N, Whyte MP, Hefferan TE, Makareeva E, Brusel M, Yaszemski MJ, Rubin CJ, Kindmark A, Roschger P, Klaushofer K, McAlister WH, Mumm S, Leikin S, Kessler E, Boskey AL, Ljunggren O, Marini JC
COL1 c -前肽裂解位点突变导致高骨量成骨不全。
植物学报,2011,32(6):598-609。doi: 10.1002 / humu.21475。2011年4月7日。
- PubMed ID
-
21344539 (PubMed视图]
- 摘要
-
成骨不全症(OI)通常是由I型前胶原基因(COL1A1/COL1A2)突变引起的。我们发现了两个在I型前胶原c -前肽切割位点有替换的孩子,这破坏了胶原成熟过程中一个独特的加工步骤,并在成骨不全症中定义了一种新的表型。患者分别由COL1A1(患者1:p.Asp1219Asn)或COL1A2(患者2:p.Ala1119Thr)突变引起轻度成骨不全。患者1 L1-L4 DXA Z-score为+3.9,pQCT vBMD为+3.1;患者2 L1-L4 DXA Z-score为0.0,pQCT vBMD为-1.8。患者骨密度与x线片骨质减少和组织形态学对比,无骨硬化。突变体前胶原加工在细胞周围和体外实验中受损。患者真皮胶原原纤维边界不规则。将pc胶原蛋白掺入基质导致骨矿化增加。FTIR成像证实,与正常或成骨不全对照相比,这两名患者的矿物质/基质比例均升高,同时骨小梁内胶原成熟度增加。 Bone mineralization density distribution revealed a marked shift toward increased mineralization density for both patients. Patient 1 has areas of higher and lower bone mineralization than controls; Patient 2's bone matrix has a mineral content exceeding even classical OI bone. These patients define a new phenotype of high BMD OI and demonstrate that procollagen C-propeptide cleavage is crucial to normal bone mineralization.